SGMO stock forecast
Our latest prediction for Sangamo Therapeutics, Inc.'s stock price was made on the Sept. 17, 2018 when the stock price was at 14.70$.
In the short term (2weeks), SGMO's stock price should underperform the market by -0.07%. During that period the price should oscillate between -8.43% and +9.93%.
In the medium term (3months), SGMO's stock price should underperform the market by -0.73%. During that period the price should oscillate between -20.32% and +26.78%.Get email alerts
About Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. engages in researching and developing transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
At the moment the company generates 71M USD in revenues.
On its last earning announcement, the company reported a loss of -0.67$ per share.
The book value per share is 3.81$
Three months stock forecastSept. 17, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|